Vetter President of Development Services USA joins iBIO board Vetter President of Development Services USA joins iBIO board Claudia Roth will offer her leadership and expertise in aseptic filling NextPharma makes three senior appointments NextPharma makes three senior appointments For liquids, pencilllins and regulatory affairs parts of the business Novasep complete its executive team Novasep complete its executive team Thierry Van Nieuwenhove joins the firm as President of the Synthesis Business Unit Changes at the top of the European Fine Chemicals Group Changes at the top of the European Fine Chemicals Group Appoints President, Vice President and Sector Group Manager Mitchell Reff becomes Chief Biologics Officer at ShangPharma Mitchell Reff becomes Chief Biologics Officer at ShangPharma He brings more than 30 years of reaearch experience to the position Novavax makes management promotions to support expanded clinical activity in 2014 Novavax makes management promotions to support expanded clinical activity in 2014 In preparation for expanded clinical trial activities over the next two years AMRI makes two leadership appointments AMRI makes two leadership appointments George Svokos joins as SVP Sales and General Manager, API while Vijay Kumar Batra becomes MD of AMRI India Jeffrey Chodakewitz to join Vertex as Chief Medical Officer Jeffrey Chodakewitz to join Vertex as Chief Medical Officer Will also be Senior Vice President of Global Medicines Development Actavis appoints new managers for its US Specialty Brands business Actavis appoints new managers for its US Specialty Brands business Four divisions will be women’s health, urology/gastroenterology, dermatology/established brands and business operations Galderma announces CEO for North American Operations Galderma announces CEO for North American Operations Stuart Raetzman will join the dermatology firm on 1 March Priaxon appoints Dr Constance Hoefer as Chief Development Officer Priaxon appoints Dr Constance Hoefer as Chief Development Officer Brings the necessary experience and knowledge for the Company to successfully advance Priaxon AG’s non-clinical programs towards the clinic Tim Tasker joins Heptares as Chief Medical Officer Tim Tasker joins Heptares as Chief Medical Officer Increases focus on clinical development of GPCR-targeted drug candidates Thomas Broeer elected as new BGMA Chairman Thomas Broeer elected as new BGMA Chairman Brings more than 20 years of industry experience to the position KaloBios hires Harry Lam as Head of Manufacturing KaloBios hires Harry Lam as Head of Manufacturing He joins the firm with more than 28 years of biopharmaceutical manufacturing experience Chris Kilbee appointed Group Director of UBM Pharma Portfolio Chris Kilbee appointed Group Director of UBM Pharma Portfolio Aims to expand the portfolio globally, putting increased emphasis on digital and content SCM Pharma appoints US business development manager SCM Pharma appoints US business development manager Derek Richards takes up the role Merck Serono appoints Steven Hildemann as Global Chief Medical Officer Merck Serono appoints Steven Hildemann as Global Chief Medical Officer He brings more than 20 years of experience to Merck Serono, across academic medicine and the pharmaceutical industry TiGenix appoints Gri-Cel CEO and COO to Board of Directors TiGenix appoints Gri-Cel CEO and COO to Board of Directors Following strategic investment of EUR12m by Grifols Sitka Biopharma appoints Sean Cunliffe as Chief Executive Sitka Biopharma appoints Sean Cunliffe as Chief Executive Canadian biotechnology firm is developing a treatment for bladder cancer Richard Sachse takes Chief Scientific Officer role at Aeterna Zentaris Richard Sachse takes Chief Scientific Officer role at Aeterna Zentaris Takes responsibility for all global research and development activities at the Canadian firm John van der Valk appointed MD of UBM Live Amsterdam John van der Valk appointed MD of UBM Live Amsterdam Takes responsibility for overseeing the company’s CPhI brand Kemal Malik joins Bayer Board of Management and takes responsibility for Innovation Kemal Malik joins Bayer Board of Management and takes responsibility for Innovation Professor Wolfgang Plischke will retire on 30 April Nuevolution appoints Ton Berkien as Chief Business Officer Nuevolution appoints Ton Berkien as Chief Business Officer He will lead the commercial and business development efforts of the Copenhagen-based firm Celerion appoints John Horkulak as Executive Director, Eurasian Site Operations Celerion appoints John Horkulak as Executive Director, Eurasian Site Operations Will help expand early phase patient capabilities in Europe and Asia